SelectEvidence by Nova Leah is a comprehensive cybersecurity risk management solution designed for medical device manufacturers and healthcare providers. It automates the process of identifying vulnerabilities, implementing security controls, and managing cybersecurity risks for connected medical devices throughout their entire lifecycle. The platform provides an intelligent, automated, and traceable approach to cybersecurity assessments, helping manufacturers meet FDA and EU cybersecurity guidance requirements for both premarket submissions and postmarket management. SelectEvidence utilizes AI, automation, and advanced repositories to enhance the risk management process, offering full traceability from risk identification to treatment. It can be deployed as a standalone system or as a collaborative solution for managing risk and information sharing between manufacturers and healthcare providers.
